SmartFSCV: An Artificial Intelligence Enabled Miniaturised FSCV Device Targeting Serotonin

IEEE Open J Eng Med Biol. 2024 Jan 19:5:75-85. doi: 10.1109/OJEMB.2024.3356177. eCollection 2024.

Abstract

Goal: Dynamically monitoring serotonin in real-time within target brain regions would significantly improve the diagnostic and therapeutic approaches to a variety of neurological and psychiatric disorders. Current systems for measuring serotonin lack immediacy and portability and are bulky and expensive. Methods: We present a new miniaturised device, named SmartFSCV, designed to monitor dynamic changes of serotonin using fast-scan cyclic voltammetry (FSCV). This device outputs a precision voltage potential between -3 to +3 V, and measures current between -1.5 to +1.5 μA with nano-ampere accuracy. The device can output modifiable arbitrary waveforms for various measurements and uses an N-shaped waveform at a scan-rate of 1000 V/s for sensing serotonin. Results: Four experiments were conducted to validate SmartFSCV: static bench test, dynamic serotonin test and two artificial intelligence (AI) algorithm tests. Conclusions: These tests confirmed the ability of SmartFSCV to accurately sense and make informed decisions about the presence of serotonin using AI.

Keywords: Artificial intelligence; device; electrochemistry; fast-scan cyclic voltammetry; serotonin.

Grants and funding

The work of Michael Berk was supported by the NHMRC Senior Principal Research Fellowship and Leadership 3 Investigator under Grants 1156072 and 2017131.